Selective internal radiation therapy of HCC and liver metastases: A locoregional or worldwide therapy?

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 3, 2009, Pages 302-304

  Lambert, B ^a   Van De Wiele, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED POPPYSEED OIL; IODINE 131; MICROSPHERE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; YTTRIUM 90;

CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG HALF LIFE; EDITORIAL; HUMAN; ISOTOPE LABELING; LIVER CELL CARCINOMA; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SELECTIVE INTERNAL RADIATION THERAPY; LIVER TUMOR; METASTASIS;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; RADIOPHARMACEUTICALS;

EID: 70349582723     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Parkin MD, Bray F, Ferlay J and Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-90.
3. Welsh JS, Kennedy AS, Thomadsen B. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006;66:S62-73.
4. Poston G. Radiofrequency ablation of colorectal liver metastases: where are we really going? J Clin Oncol 2005;23:1342-4.
5. Seifert J, Junginger T, Morris D. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998;43:141-54. (Pubitemid 28306028)
6. Bilchik A, Wood T, Allegra D. Radiofrequency ablation of unresectable hepatic malignancies. Lessons learned. Oncologist 2001;6:24-33.
7. Wood T, Rose D, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations and complications. Ann Surg Oncol 2000;7:593-600.
8. Gilliams A. Image guided tumor ablation. Cancer Imaging 2005;21:103-9.
9. Salem R, Thurston K. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 2006;17:1571-93. (Pubitemid 44596135)
10. Lambert B, Van de Wiele C. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2005;32:980-9. (Pubitemid 41205671)
11. Salem R, Thurston K. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodological considerations. J Vasc Interv Radiol 2006;8:1251-77.
12. Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P et al. Prospective randomized trial of chemoembolization versus intra-arterial injection of 1311-labeled iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997;26:1156-61.
13. Stepan V, Davidkova M. Impact of oxygen concentrations on yields of DNA damages caused by ionizing radiation. J Physics 2008;DOI.1088/1472-6596/101/ 012015
14. Ho S, Lau WY, Leung TW, Chan M, Ngar YK, Johnson PJ et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 1996;23:947-52. (Pubitemid 26278795)
15. Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997;24:293-8. (Pubitemid 27165858)
16. Ho S, Lau WY, Leung TW, Chan M, Chan KW, Lee WY et al. Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 1997;70:823-8.